Thomas Meier
Chief Executive Officer bij BACHEM HOLDING AG
Vermogen: 1 M $ op 29-02-2024
Profiel
De heer Thomas Meier is Chief Executive Officer bij Bachem Holding AG en Voorzitter van de Raad van Toezicht bij Bachem AG. Hij is lid van de Raad van Bestuur van Bachem (U.K.) Ltd. (UK).
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
31-12-2022 | 15 020 ( 0.02% ) | 1 M $ | 29-02-2024 |
Actieve functies van Thomas Meier
Bedrijven | Functie | Begin |
---|---|---|
BACHEM HOLDING AG | Chief Executive Officer | 01-01-2020 |
Bachem (U.K.) Ltd.
Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The private company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Director/Board Member | 11-12-2018 |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Chairman | 01-01-1993 |
Opleiding van Thomas Meier
Zhaw School of Engineering | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BACHEM HOLDING AG | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Bachem (U.K.) Ltd.
Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The private company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Health Technology |